Contact this trialFirst, we need to learn more about you.
Semaglutide for Type 2 Diabetes
Recruiting0 awardsPhase 2
Maumee, Ohio
This trial is testing whether semaglutide can help control blood sugar and weight in people with type 2 diabetes who are also overweight, when taken with metformin. It will compare different doses of semaglutide, given by injection, to placebo (a dummy medicine). The trial will last for 52 weeks, with participants having 13 clinic visits and 4 phone calls.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.